A Novel Drug for Biodefense and Emerging Infectious Diseases

Information

• Research Project
• 8753200

• ApplicationId

  8753200

• Core Project Number

  N01AI000000

• Full Project Number

  272201300018C-0-0-1

• Serial Number

• FOA Number

• Sub Project Id

• Project Start Date

  9/16/2013 - 11 years ago

• Project End Date

  3/15/2015 - 9 years ago

• Program Officer Name

• Budget Start Date

  -

• Budget End Date

  -

• Fiscal Year

  2013

• Support Year

• Suffix

• Award Notice Date

  -

Organizations

• TRIUS THERAPEUTICS, INC.

This contract supports the advanced development of promising therapeutic candidates with broad spectrum activity. The research and development activities to be supported will allow candidate therapeutic products to progress through the product development pipeline, and includes preclinical and non-clinical activities, as well as IND development activities.

IC Name

• Activity

  N01

• Administering IC

  AI

• Application Type

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  3624974

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:3624974\

• Funding Mechanism

  Non SBIR/STTR Contracts

• Study Section

• Study Section Name

• Organization Name

  TRIUS THERAPEUTICS, INC.

• Organization Department

• Organization DUNS

  171547339

• Organization City

  SAN DIEGO

• Organization State

  CA

• Organization Country

  UNITED STATES

• Organization Zip Code

  921213209

• Organization District

  UNITED STATES